Data / Form D filings / AJNA BioSciences PBC
AJNA BioSciences PBC: Form D filings
AJNA BioSciences PBC, a pharmaceuticals company in Littleton, CO, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on June 10, 2024, reports $2.1 million sold of a $2.1 million offering to 57 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8022 Southpark Circle, Suite 500, Littleton, CO, 80120
- Phone
- (720) 615-0515
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1900590
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2024 | New notice | $2,105,106 | $2,105,106 | 57 | May 28, 2024 | sec.gov | |
| Dec 21, 2021 | New notice | $6,870,000 | $6,870,000 | 27 | Sep 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joel Stanley | Executive Officer, Director | |
| Jesse Stanley | Director |
Every Form D from the week of Jun 10, 2024 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AJNA BioSciences PBC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.